Michael Sabel

15.4k citations
223 papers · 12.2k · 3 hit papers · h-index 58

Impact in

Papers in

    • Glioma Diagnosis and Treatment 115
    • Cancer Genomics and Diagnostics 9
    • Cancer, Hypoxia, and Metabolism 7

Michael Sabel

217 papers receiving 12.0k citations

Michael Sabel's Hit Papers

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial 2019 · 431 citations
4310+5+11Years since publication250500750

Peers

Michael Sabel
Comparison fields: 5 of 149
  • Genetics 7.7k
  • Cancer Research 2.1k
  • Radiology, Nuclear Medicine and Imaging 2.1k
  • Pulmonary and Respiratory Medicine 2.3k
  • Neurology 851
Replace David R. Macdonald with:
David R. Macdonald Canada
Dominique Figarella-Branger France
Andrew B. Lassman United States
David G Brachman United States
Antje Wick Germany
Nicholas Arthur Butowski United States
Phioanh Leia Nghiemphu United States
Yaning Chen China
Arnab Chakravarti United States
Benjamin M. Ellingson United States
Michael Sabel relative to David R. Macdonald Canada David R. Macdonald's profile →
Citations per field
00.5×1.5×1.9×
David R. Macdonald · 1×
Citations per year

Countries citing papers authored by Michael Sabel

Since Specialization
Citations

This map shows the geographic impact of Michael Sabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sabel more than expected).

Fields of papers citing papers by Michael Sabel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sabel. The network helps show where Michael Sabel may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Sabel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Sabel Line = papers co-authored together Michael Sabel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 223 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Hit paper breakdown →
2012908
2 2007720
3
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Hit paper breakdown →
2009666
4
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2019431
5 2015271
6 2011262
7 2015259
8 2010239
9 2014219
10 2016206
11 2013199
12 2016186
13 2019184
14 2009175
15 2015166
16 2009160
17 2005158
18 2007157
19 2016157
20 2017157

About Michael Sabel

Michael Sabel is a scholar working on Genetics, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Neurology, having authored 223 papers that have together received 12.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (115 papers), Brain Metastases and Treatment (20 papers), Medical Imaging Techniques and Applications (16 papers), Meningioma and schwannoma management (14 papers), Cancer Genomics and Diagnostics (9 papers), Radiomics and Machine Learning in Medical Imaging (9 papers), Photodynamic Therapy Research Studies (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Genetics (7.7k citations), Cancer Research (2.1k citations), Radiology, Nuclear Medicine and Imaging (2.1k citations), Pulmonary and Respiratory Medicine (2.3k citations) and Neurology (851 citations). Michael Sabel has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Guido Reifenberger, Marion Rapp, Jörg Felsberg, Karl‐Josef Langen, Gabriele Stoffels, Michael Weller, Hans‐Jakob Steiger, Walter Stummer, Marcel Alexander Kamp and Matthias Simon. Their work appears in journals such as Neuro-Oncology, Acta Neurochirurgica, Journal of Neuro-Oncology, Journal of Nuclear Medicine and World Neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact